The Discounted Cash Flow (DCF) valuation of Ocular Therapeutix Inc (OCUL) is (25.86) USD. With the latest stock price at 11.08 USD, the upside of Ocular Therapeutix Inc based on DCF is -333.4%.
Based on the latest price of 11.08 USD and our DCF valuation, Ocular Therapeutix Inc (OCUL) is a sell. selling OCUL stocks now will result in a potential gain of 333.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 8.1% | 6.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (106.50) - (14.52) | (25.86) |
| Upside | -1061.2% - -231.0% | -333.4% |